A PHASE 1/2 STUDY OF REGN5093 IN PATIENTS WITH MET-ALTERED ADVANCED NON-SMALL CELL LUNG CANCER
Clinical Trial Grant
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
January 2, 2020
End Date
December 15, 2020
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
January 2, 2020
End Date
December 15, 2020